DIA
AUPH icon

Dana Investment Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

Dana Investment Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,459
Closed -$379K – 401
2022
Q3 		$379K Buy
50,459
+1,306
+3% +$11.3K 0.02% 334
2022
Q2 		$494K Sell
49,153
-3,222
-6% -$36K 0.03% 310
2022
Q1 		$648K Sell
52,375
-1,022
-2% -$15.8K 0.03% 249
2021
Q4 		$1.22M Sell
53,397
-15,183
-22% -$360K 0.05% 205
2021
Q3 		$1.52M Sell
68,580
-33,919
-33% -$538K 0.07% 180
2021
Q2 		$1.33M Sell
102,499
-4,840
-5% -$61.7K 0.06% 196
2021
Q1 		$1.39M Buy
+107,339
New +$1.56M 0.06% 192

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Dana Investment Advisors's AUPH Position: Q4 2022 in Review

Dana Investment Advisors sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 50,459 shares — an estimated $379K sold.

Dana Investment Advisors first reported a position in AUPH in Q1 2021 and held it in 7 quarters. The position peaked at $1.52M in Q3 2021. 191 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

  • Dana Investment Advisors reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Dana Investment Advisors sold 50,459 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $379K.
  • Dana Investment Advisors first reported a position in Aurinia Pharmaceuticals in Q1 2021 and held it in 7 quarters.
  • Dana Investment Advisors's Aurinia Pharmaceuticals position peaked at $1.52M in Q3 2021.
  • 191 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on Dana Investment Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.